Don't be afraid: very old patients treated with Vitamin K antagonists, if adequately managed, benefit from anticoagulati

Results of the EPICA Study (Elderly Patients followed by Italian Centres for Anticoagulation Study), were presented at the ESC Congress 2011 today. This is the largest study on very old patients anticoagulated with Vitamin K antagonists for the prevention of venous thromboembolism and, for the major part (75%), for the prevention of stroke because affected by atrial fibrillation.

Read the whole article on Physorg

More from Physorg